Take Action Today to Protect Medical Research Funding

AABB continues to be a strong advocate for research that drives innovation and advancements in transfusion medicine and biotherapies. As Congress works to finalize fiscal year (FY) 2026 federal research funding, your support is critical to advancing this advocacy.

The National Institutes of Health (NIH) plays a vital role in advancing medical innovation, ensuring national security and maintaining public health preparedness. However, funding for NIH is at risk in the FY 2026 appropriations process.

NIH-funded research has led to groundbreaking advancements in blood safety, biotherapies, and innovative treatments such as chimeric antigen receptor T-cell (CAR-T) therapy and tumor-infiltrating lymphocytes (TIL) technologies. These developments are vital for treating hematologic malignancies, solid tumor cancers and complications related to transfusions in both civilian and military populations.

TAKE ACTION NOW: Send a message to your members of Congress asking them to support robust NIH funding. Every dollar of federal research funding generates an estimated $2.46 in economic activity across the U.S. 

Your advocacy is crucial in ensuring continued medical progress and national preparedness.